Prescribing Hemodialysis

A Guide to Urea Modeling

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Nephrology, General
Cover of the book Prescribing Hemodialysis by T.A. Depner, Springer US
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: T.A. Depner ISBN: 9781461315094
Publisher: Springer US Publication: December 6, 2012
Imprint: Springer Language: English
Author: T.A. Depner
ISBN: 9781461315094
Publisher: Springer US
Publication: December 6, 2012
Imprint: Springer
Language: English

What regulation shall we have for the operation? Shall a man transfuse he knows not what. to correct he knows not what. God knows how (l)? Dr. Henry Stubbs Royal College of Physicians circa 1670 If dialysis therapy were a new phannaceutical product being evaluated by the FDA now, it might not be approved for marketing. The recommended dose, its potential toxicity, the side effects of under-or over-dialysis as well as its efficacy have been the subject of very few studies. The high mortality rate associated with the treatment may raise a few eyebrows. That it is a life-saving modality of treatment is undoubtedly true for more than 100,000 patients in the United States and for more than a million patients world­ wide. Because dialysis has extended the lives of many people by a variable period of time, most nephrologists have "rested on their laurels" and did not vigorously pursue studies to optimize these treatments. But facts have a way of intruding in all our lives and the facts are that the overall mortality rate of dialysis patients in the United States is rising and stands close to 25% per year and is closer to 33% per year for patients between the ages of 65 and 74 (2). These mortality figures are considerably higher for age-adjusted dialysis populations in Europe and particu­ larly in Japan, and certainly for the age-adjusted nonnal population.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

What regulation shall we have for the operation? Shall a man transfuse he knows not what. to correct he knows not what. God knows how (l)? Dr. Henry Stubbs Royal College of Physicians circa 1670 If dialysis therapy were a new phannaceutical product being evaluated by the FDA now, it might not be approved for marketing. The recommended dose, its potential toxicity, the side effects of under-or over-dialysis as well as its efficacy have been the subject of very few studies. The high mortality rate associated with the treatment may raise a few eyebrows. That it is a life-saving modality of treatment is undoubtedly true for more than 100,000 patients in the United States and for more than a million patients world­ wide. Because dialysis has extended the lives of many people by a variable period of time, most nephrologists have "rested on their laurels" and did not vigorously pursue studies to optimize these treatments. But facts have a way of intruding in all our lives and the facts are that the overall mortality rate of dialysis patients in the United States is rising and stands close to 25% per year and is closer to 33% per year for patients between the ages of 65 and 74 (2). These mortality figures are considerably higher for age-adjusted dialysis populations in Europe and particu­ larly in Japan, and certainly for the age-adjusted nonnal population.

More books from Springer US

Cover of the book A Practical Introduction to Hardware/Software Codesign by T.A. Depner
Cover of the book Research Methods for Therapists by T.A. Depner
Cover of the book Security Informatics by T.A. Depner
Cover of the book The Neurobiologic Mechanisms in Manipulative Therapy by T.A. Depner
Cover of the book Encyclopedia of Prehistory by T.A. Depner
Cover of the book Contemporary Nephrology by T.A. Depner
Cover of the book The Justice Motive as a Personal Resource by T.A. Depner
Cover of the book Blood Cell Biochemistry by T.A. Depner
Cover of the book Petrology of Lamproites by T.A. Depner
Cover of the book Cancer Immunology: Innovative Approaches to Therapy by T.A. Depner
Cover of the book Fulfilling the Export Potential of Small and Medium Firms by T.A. Depner
Cover of the book The Unknown Component Problem by T.A. Depner
Cover of the book EMI/EMC Computational Modeling Handbook by T.A. Depner
Cover of the book Air Pollution Modeling by T.A. Depner
Cover of the book Advances in Clinical Child Psychology by T.A. Depner
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy